The association between continuous positive airway pressure therapy and liver disease development in obstructive sleep apnea/hypopnea syndrome patients: a nationwide population-based cohort study in Taiwan

Sleep and Breathing

Volumn 21, Issue 2, 2017, Pages 461-467

  Hang, Liang Wen ^a,b,c   Chen, Chi Fung ^a   Wang, Chang Bi ^a   Wu, Trong Neng ^a,d   Liang, Wen Miin ^a   Chou, Tzu Chieh ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Cohort; CPAP treatment; Liver disease; OSAHS; Population based study

Indexed keywords

ADULT; ARTICLE; ATRIAL FIBRILLATION; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; HUMAN; HYPERLIPIDEMIA; ICD-9; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; POPULATION BASED COHORT STUDY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; TAIWAN; THERAPY EFFECT; AGED; FOLLOW UP; INCIDENCE; LIVER CIRRHOSIS; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PROPENSITY SCORE; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; COHORT STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROPENSITY SCORE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TAIWAN;

EID: 85003894411     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-016-1439-4     Document Type: Article

References (33)

1. Punjabi NM, Caffo BS, Goodwin JL et al (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6:e1000132
2. Franklin KA, Lindberg E (2015) Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis 7:1311–1322
3. McNicholas WT, Bonsignore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29:156–178
4. Sun H, Shi J, Li M et al (2013) Impact of continuous positive airway pressure treatment on left ventricular ejection fraction in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. PLoS One 8:e62298
5. Engleman HM, Kingshott RN, Martin SE et al (2000) Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep 23:S102–S108
6. Ulfberg J, Carter N, Edling C (2000) Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health 26:237–242
7. Mar J, Rueda JR, Duran-Cantolla J et al (2003) The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J 21:515–522
8. Hui DS, Shang Q, Ko FW et al (2012) A prospective cohort study of the long-term effects of CPAP on carotid artery intima-media thickness in obstructive sleep apnea syndrome. Respir Res 13:22
9. de Araujo MT, Bissoli NS, Gouvea SA et al (2013) CPAP therapy prevents increase in blood pressure after upper airway surgery for obstructive sleep apnoea. Sleep Breath 17:1289–1299
10. Iftikhar IH, Khan MF, Das A et al (2013) Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes. Ann Am Thorac Soc 10:115–120
11. Mirrakhimov AE, Polotsky VY (2012) Obstructive sleep apnea and non-alcoholic fatty liver disease: is the liver another target? Front Neurol 3:149
12. Chou TC, Liang WM, Wang CB et al (2015) Obstructive sleep apnea is associated with liver disease: a population-based cohort study. Sleep Med 16:955–960
13. Younossi ZM, Diehl AM, Ong JP (2002) Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 35:746–752
14. Donnelly KL, Smith CI, Schwarzenberg SJ et al (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343–1351
15. Madan K, Bhardwaj P, Thareja S et al (2006) Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 40:930–935
16. Harsch IA, Schahin SP, Radespiel-Tröger M et al (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156–162
17. Kylstra WA, Aaronson JA, Hofman WF et al (2013) Neuropsychological functioning after CPAP treatment in obstructive sleep apnea: a meta-analysis. Sleep Med Rev 17:341–347
18. Lavie L, Lavie P (2008) Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med 9:247–253
19. Riha RL, Gislasson T, Diefenbach K (2009) The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome. Eur Respir J 33:646–655
20. Lin CY, Shih TS, Liou SH et al (2015) Predictors for progression of sleep disordered breathing among public transport drivers: a 3-year follow-up study. J Clin Sleep Med 11:419–425
21. Corey KE, Misdraji J, Zheng H et al (2013) The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery. PLoS One 8:e62504
22. Jouet P, Sabate JM, Maillard D et al (2007) Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study. Obes Surg 17:478–485
23. Bonsignore MR, Esquinas C, Barcelo A et al (2012) Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J 39:1136–1143
24. Savransky V, Bevans S, Nanayakkara A et al (2007) Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293:G871–G877
25. Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147–152
26. Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7:677–685
27. Edmison MA (2007) Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 11:75–104
28. Turkay C, Ozol D, Kasapoglu B et al (2012) Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia. Respir Care 57:244–249
29. Lamphere J, Roehrs T, Wittig R et al (1989) Recovery of alertness after CPAP in apnea. Chest 96:1364–1367
30. Gordon P, Sanders MH (2005) Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome. Thorax 60:68–75
31. Xu H, Yi H, Guan J et al (2014) Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials. Atherosclerosis 234:446–453
32. Yang MC, Lin CY, Lan CC et al (2013) Factors affecting CPAP acceptance in elderly patients with obstructive sleep apnea in Taiwan. Respir Care 58:1504–1513
33. Stepnowsky CJ Jr, Marler MR, Ancoli-Israel S (2002) Determinants of nasal CPAP compliance. Sleep Med 3:239–247